Ravindra Pandey, a researcher at Roswell Park Comprehensive Cancer Center and research professor at UB, has been named a fellow of the National Academy of Inventors (NAI).

Pandey is among 162 individuals — who collectively hold more than 4,600 U.S. patents — named as fellows, a distinction considered among the highest awarded to academic inventors.

The NAI Fellows Selection Committee chose Pandey for a fellowship in recognition of his “spirit of innovation” and inventions “that have made a tangible impact on the quality of life, economic development, and welfare of society.”

A pioneer in photodynamic therapy (PDT), a cancer therapy developed at Roswell, Pandey has published more than 300 research papers and holds 41 patents. PDT is FDA-approved to treat several types of cancer.

He is the founder of the Roswell spinoff company Photolitec LLC and a past winner of several Western New York Inventor of the Year Awards.  

A member of the Roswell staff for more than three decades, Pandey currently serves as director of pharmaceutical chemistry. In addition to his position as research professor at UB, Pandey is affiliated with the university’s Institute for Lasers, Photonics and Biophotonics.